Form 4: Johnson & Johnson Executive Reports Stock Transactions
Statement of Changes in Beneficial Ownership
Johnson & Johnson executive John C. Reed reported transactions involving restricted stock units and common stock, including awards under the company's Long-Term Incentive Plan.
Summary
- John C. Reed, EVP of Innovative Medicine, R&D at Johnson & Johnson, reported transactions on May 1, 2026.
- Reed acquired 25,255 Restricted Share Units (RSUs) awarded under the Issuer's Long-Term Incentive Plan.
- These RSUs vest in three equal annual installments starting May 1, 2024, and convert to Common Stock upon vesting.
- Additionally, 11,002 shares were disposed of, with shares withheld for tax payments upon RSU vesting.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine executive compensation and tax-related stock transactions rather than significant strategic shifts or performance indicators.
Positives
- Award of 25,255 Restricted Share Units under the Long-Term Incentive Plan, indicating continued equity-based compensation for executive performance.
- Vesting schedule for RSUs provides a structured incentive over three years.
Negatives
- Disposition of 11,002 shares, with a portion withheld for tax payments, representing a reduction in directly held shares.
Future Outlook
The filing does not contain forward-looking statements or guidance. It reports on past transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive stock dealings. This specific filing details routine equity awards and tax-related share dispositions, common practices in the pharmaceutical and healthcare industry.
Stakeholder Impact
- Shareholders: Increased transparency into executive compensation and stock holdings.
- Employees: Reinforces the company's use of equity incentives for key personnel.
- Management: Reflects standard executive compensation practices.
Next Steps
- Continued vesting of Restricted Share Units over the next two years.
- Potential future transactions by the reporting person as per their compensation plan and personal financial decisions.
Key Dates
| Date | Description |
|---|---|
| 05/01/2026 | Transaction Date for acquisition of RSUs and disposition of shares. |
| 05/01/2023 | Grant date for Restricted Share Units (RSUs). |
| 05/01/2024 | First anniversary of the grant date, marking the beginning of the RSU vesting period. |
| 05/04/2026 | Date of filing for the Form 4. |
Keywords
Johnson & Johnson, JNJ, Form 4, Insider Trading, Restricted Stock Units, Long-Term Incentive Plan, Executive Compensation, Stock Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.